Edgar Tracker

LCTX Lineage Cell Therapeutics, Inc.

NYSE · CIK 876343 · Biological Products, (No Diagnostic Substances)

SEC company page

Public articles

No public articles yet. Follow LCTX to track filings and write notes.

Recent filings

–

Form Filed Title Accession
10-Q2026-08-0610-Q0001193125-26-338064
8-K2026-08-062.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001193125-26-338020
SCHEDULE 13G2026-07-29—0002012383-26-002817
8-K2026-06-125.07 Submission of Matters to a Vote of Security Holders · 8.01 Other Events0001193125-26-269557
10-Q2026-05-1210-Q0001193125-26-219479
8-K2026-05-122.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001193125-26-219421
ARS2026-04-29ARS0001193125-26-191714
DEFA14A2026-04-29DEFA14A0001193125-26-191616
DEF 14A2026-04-29DEF 14A0001193125-26-191556
EFFECT2026-03-23—9999999995-26-000908
CORRESP2026-03-19—0001193125-26-116059
UPLOAD2026-03-16—0000000000-26-002663
S-32026-03-11S-30001193125-26-101168
8-K2026-03-118.01 Other Events · 9.01 Financial Statements and Exhibits0001193125-26-101167
424B52026-03-11424B50001193125-26-101166
10-K2026-03-0510-K0001193125-26-093992
8-K2026-03-052.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001193125-26-093948
8-K2025-11-288.01 Other Events0001193125-25-302552
8-K2025-11-248.01 Other Events0001193125-25-291979
SCHEDULE 13D/A2025-11-14—0000919574-25-007051